G. Turenne
Amministratore Delegato presso Matchpoint Therapeutics, Inc.
Profilo
G.
Andre Turenne currently works at Matchpoint Therapeutics, Inc., as President & Chief Executive Officer and Atlas Venture Advisors, Inc., as Advisor.
Mr. Turenne also formerly worked at Voyager Therapeutics, Inc., as President, Chief Executive Officer & Director, Genzyme Corp., as Head-Global Strategy & Business Development from 2012 to 2015, and Sanofi Corp., as Senior VP, Head-Business Development & Licensing from 2015 to 2018.
Mr. Turenne received his undergraduate degree from Kalamazoo College and Masters Business Admin degree in 2006 from Tuck School of Business at Dartmouth.
Posizioni attive di G. Turenne
Società | Posizione | Inizio |
---|---|---|
Matchpoint Therapeutics, Inc.
Matchpoint Therapeutics, Inc. BiotechnologyHealth Technology Matchpoint Therapeutics, Inc. is a biotechnology company based in Cambridge, MA. The company aims to discover and develop precision covalent medicines to transform the treatment of immune diseases and other serious illnesses. Matchpoint's proprietary Advanced Covalent Exploration (ACE) platform integrates advanced chemoproteomics, machine learning, and covalent chemistry library evolution. The company was founded by Jianwei Che, Edward Chouchani, Tinghu Zhang, Nathanael S. Gray, and the CEO is G. Andre Turenne. | Amministratore Delegato | - |
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Consulente / Consigliere | - |
Precedenti posizioni note di G. Turenne
Società | Posizione | Fine |
---|---|---|
Sanofi Corp. | Corporate Officer/Principal | 01/03/2018 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/01/2015 |
VOYAGER THERAPEUTICS, INC. | Amministratore Delegato | - |
Formazione di G. Turenne
Kalamazoo College | Undergraduate Degree |
Tuck School of Business at Dartmouth | Masters Business Admin |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
VOYAGER THERAPEUTICS, INC. | Health Technology |
Aziende private | 4 |
---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Sanofi Corp. | |
Matchpoint Therapeutics, Inc.
Matchpoint Therapeutics, Inc. BiotechnologyHealth Technology Matchpoint Therapeutics, Inc. is a biotechnology company based in Cambridge, MA. The company aims to discover and develop precision covalent medicines to transform the treatment of immune diseases and other serious illnesses. Matchpoint's proprietary Advanced Covalent Exploration (ACE) platform integrates advanced chemoproteomics, machine learning, and covalent chemistry library evolution. The company was founded by Jianwei Che, Edward Chouchani, Tinghu Zhang, Nathanael S. Gray, and the CEO is G. Andre Turenne. | Health Technology |
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Finance |
- Borsa valori
- Insiders
- G. Turenne